These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21266301)
1. A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. Winstanley EL; Bigelow GE; Silverman K; Johnson RE; Strain EC J Subst Abuse Treat; 2011 Apr; 40(3):255-64. PubMed ID: 21266301 [TBL] [Abstract][Full Text] [Related]
2. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. Umbricht A; DeFulio A; Winstanley EL; Tompkins DA; Peirce J; Mintzer MZ; Strain EC; Bigelow GE Drug Alcohol Depend; 2014 Jul; 140():92-100. PubMed ID: 24814607 [TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Petrakis I; Carroll KM; Nich C; Gordon L; Kosten T; Rounsaville B Drug Alcohol Depend; 1998 May; 50(3):221-6. PubMed ID: 9649975 [TBL] [Abstract][Full Text] [Related]
4. A controlled trial of fluoxetine in crack cocaine dependence. Batki SL; Washburn AM; Delucchi K; Jones RT Drug Alcohol Depend; 1996 Jun; 41(2):137-42. PubMed ID: 8809502 [TBL] [Abstract][Full Text] [Related]
5. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866 [TBL] [Abstract][Full Text] [Related]
6. Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use. Carroll KM; DeVito EE; Yip SW; Nich C; Sofuoglu M Am J Addict; 2019 Jul; 28(4):238-245. PubMed ID: 31165574 [TBL] [Abstract][Full Text] [Related]
7. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. Dunn KE; Sigmon SC; Thomas CS; Heil SH; Higgins ST J Appl Behav Anal; 2008; 41(4):527-38. PubMed ID: 19192857 [TBL] [Abstract][Full Text] [Related]
9. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Oliveto A; Poling J; Mancino MJ; Feldman Z; Cubells JF; Pruzinsky R; Gonsai K; Cargile C; Sofuoglu M; Chopra MP; Gonzalez-Haddad G; Carroll KM; Kosten TR Drug Alcohol Depend; 2011 Jan; 113(2-3):184-91. PubMed ID: 20828943 [TBL] [Abstract][Full Text] [Related]
10. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Petrakis IL; Carroll KM; Nich C; Gordon LT; McCance-Katz EF; Frankforter T; Rounsaville BJ Addiction; 2000 Feb; 95(2):219-28. PubMed ID: 10723850 [TBL] [Abstract][Full Text] [Related]
11. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600 [TBL] [Abstract][Full Text] [Related]
12. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Dallery J; Silverman K; Chutuape MA; Bigelow GE; Stitzer ML Exp Clin Psychopharmacol; 2001 Aug; 9(3):317-25. PubMed ID: 11534542 [TBL] [Abstract][Full Text] [Related]
13. [Fluoxetine (FX) efficacy in the treatment of cocaine dependence methadone maintenance patients. Interaction with plasma levels]. Baño MD; Agujetas M; López ML; Tena T; Rodríguez A; Lora-Tamayo C; Guillén JL Actas Esp Psiquiatr; 1999; 27(5):321-4. PubMed ID: 10545663 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. Grabowski J; Rhoades H; Elk R; Schmitz J; Davis C; Creson D; Kirby K J Clin Psychopharmacol; 1995 Jun; 15(3):163-74. PubMed ID: 7635993 [TBL] [Abstract][Full Text] [Related]
15. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial. Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397 [TBL] [Abstract][Full Text] [Related]
16. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887 [TBL] [Abstract][Full Text] [Related]
17. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098 [TBL] [Abstract][Full Text] [Related]
18. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601 [TBL] [Abstract][Full Text] [Related]
19. Voucher-based reinforcement of opiate abstinence during methadone detoxification. Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479 [TBL] [Abstract][Full Text] [Related]
20. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]